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e.2012.12Abstract An understanding of HIV/AIDS is important to the practice of colon and rectal surgery
as these patients frequently present with proctological diseases. Operations for anorectal pathology
represent one of the most common indications for surgery in HIV-positive patients. It appears that
anorectal pathology in HIV/AIDS infected patients has not been impacted by highly active anti ret-
roviral therapy. The general approach to the HIV- infected patient and management of the anorec-
tal diseases are discussed. Surgical procedures can be safe and effective therapeutic modalities.
Symptomatic improvement of the underlying anorectal pathology may make delayed wound heal-
ing an acceptable complication in many AIDS patients. Part of the complete treatment includes
education, treatment and counselling of sexual partners.
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.0011. Introduction
Human immunodeﬁciency virus (HIV) is an RNA retrovirus
that infects human T lymphocytes. It is transmitted by con-
taminated body ﬂuids and, after a variable latent period of
5–10 years, it produces diminished immunological function
which manifests as the acquired immunodeﬁciency syndrome
(AIDS). The suppressed cellular immunity allows the develop-
ment of malignancies (Kaposi’s sarcoma, lymphoma) and
opportunistic infections (Pneumocystis carinii pneumonia,and hosting by Elsevier B.V. All rights reserved.
164 E.P. Weledjicryptosporidium, cytomegalovirus (CMV), herpes simplex
virus (HSV), varicella zoster virus (VZV) and fungi (can-
dida)).1 There is no cure but the highly active antiretroviral
treatment (HAART) prolongs survival in some patients. Since
its discovery in 1981,1 AIDS has rivalled the worse epidemics
in history with the highest prevalence in sub-Saharan Africa.
As of 2004 an estimated 25 million people have died, and
40 million are living with AIDS.2 The incidence of HIV infec-
tion has apparently leveled in the USA and Western Europe
and the mortality from these infections has decreased as
HAART has become widely available.2 Surgical presentation
is with anorectal complaints (40%), requests for venous access
(20%), cutaneous manifestations (20%), abdominal pain, re-
quests for biopsy and others (20%).3
HIV is one of the sexually transmitted organisms that affect
the anorectum. Other viral organisms include cytomegalovirus,
herpes simplex virus (HSV), human papilloma virus (condylo-
mata acuminatum), and molluscum contagiosum. Bacterial
organisms include Campylobacter jejuni, Chlamydia tracho-
matis, Lymphogranuloma venereum, Haemophilus ducreyi
(chancroid), Neisseria gonorrhoeae (gonorrhoea), Donovania
granulomatis (granuloma inguinale) and Treponema pallidum
(syphilis). The presence of more than one offending organism
is common and the presenting symptoms may range from gas-
trointestinal (diarrhoea, rectal bleeding) to visible lesions in the
anus and perineum.4 The diarrhoea associated with the oppor-
tunistic colonic infections (CMV and bacterial colitis), is severe
and encourages anal ulceration. The more typically regarded
organisms that cause sexually transmitted diseases (STDs)
including HIV involving the anorectum present with two main
symptom complexes; proctitis or perianal ulceration.4 For the
malignancies, Kaposi’s sarcoma may resemble an ulcerated
haemorrhoid, non-Hodgkin’s lymphoma may resemble a peri-
anal abscess and squamous cell carcinoma may be mistaken
for a small benign ulcer.
The increased prevalence and variety of STDs seen in the
Western world have been attributed to greater promiscuity,
homosexuality and the use of the anorectum for sexual grati-
faction.5 Unprotected anoreceptive sex and multiple partners
are two common behaviours among homosexual males that
put them at increased risk for anorectal STDs. Females are
also affected by anorectal STDs, with more than 10% of
American women and their male consorts engaging in anorec-
tal sexual activity.5 Paramount to the diagnosis of these dis-
eases is a thorough history about sexual practices. These
discussions may be uncomfortable for the patient and practi-
tioner, but without them the proper diagnosis is likely to be
missed. The aim of this review is to present and assess the proc-
tological diseases related to HIV/AIDS and the implications
on surgical management.
2. Method
Electronic searches of the Medline (PubMed) database,
Cochrane library, and science citation index were performed
to identify original published studies on HIV/AIDS and ano-
rectal disorders. Relevant articles were searched from relevant
chapters in specialized texts and all included.
The general approach to the HIV-infected patient with
proctological complaints start with a thorough history, which
includes presenting symptoms, bowel and sphincter function,sexual practices, the number and gender of sexual partners
from the past 12 months, use of protection, past history of
STDs, past HIV testing and prior anorectal surgery. Part of
the complete treatment of STDs including HIV includes edu-
cating the patient as to the mode of transmission and ways
to avoid subsequent reinfection. This frequently includes treat-
ment and counselling of sexual partners.4,5 The current anti
retroviral treatment the patient is taking as well as CD4 counts
and viral load are determined. The decision to undertake sur-
gery is aided by staging patients according to their level of gen-
eral immunity (CDC stages I–IV) The CD4 T-lymphocyte
categories are, category 1 (>500 cells/ll), category 2 (200–
499 cells/ll), and category 3 (<200 cells/ll). A CD4 level of
greater than 500 indicates mild disease and implies that appro-
priate operative treatment should not be withheld. A CD4 level
of less than 500 indicates advanced disease and an exceedingly
poor outcome.7,25 The pathophysiological consequences of ad-
vanced disease (e.g. immunosuppression, malnutrition, infec-
tions and neoplasms) could dictate the scaling down of the
magnitude of surgery to an acceptable and safe level.
However, CD4 studies of the value of viral loads and CD4
counts (alone or in combination) in predicting operative mor-
bidity and mortality did not produce conclusive results and
these tests are not ideal for every day practical use.8,11
The four factors that have been found to increase operative
morbidity and mortality in HIV/AIDS patients are: a compro-
mised physiological state (a poor American Society of Anaes-
thesiology-ASA or Korsakoff’s performance score),
physiologically demanding surgery, emergency surgery, and
operations in contaminated ﬁelds, e.g. anorectum or oral cav-
ity.8 In the current HAART era, patients have an improved
general resistance to infection and are nutritionally better.30
Postponing elective operations with the aim of starting the pa-
tient on antiretroviral medication to improve the CD4 count
should be encouraged.8 Special protective procedures, for
example the use of prophylactic antibiotics is essential when
dealing with these patients.3
3. Anorectal problems in AIDS patients
Operations for anorectal pathology represent one of the most
common indications for surgery in HIV-positive patients.3,4
The improved surgical outcomes together with the preventive
measures against occupational HIV transmission have resulted
in the treatment of HIV/AIDS patients becoming an accepted
part of routine surgical practice.8,11,30 With increasing survival
of HIV/AIDS patients on HAART the other non-AIDS re-
lated anorectal disorders requiring treatment predominate.
Two-thirds of AIDS patients needing surgical treatment for
anorectal disease such as symptomatic haemorrhoids, perianal
sepsis were rendered symptom-free. So treatment is well worth
doing as the survival is close to the survival of patients with
AIDS who did not have anorectal disease.4,11 One concern in
taking care of these patients is how their disease affects wound
healing. It appears that patients who are HIV positive without
AIDS have no increased risk of wound problems, while those with
AIDS are more likely to have delayed wound healing.8–10,26 There
are minimal problems with wound healing if wound care for
HIV-AIDS patients incorporate the WHO suggestions or the
UK NICE guidelines for reduction of wound infection.9
Sphincter preservation is of utmost importance during all anal
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wards incontinence and the diarrhoea associated with opportu-
nistic colonic infections is often severe. The HIV also has a
predilection for the external anal sphincter predisposing urge
(active) incontinence.4,184. Proctological diseases
HIV/AIDS patients frequently present with proctological dis-
eases divided into three categories4: (1) Proctological com-
plaints common to the population at large (e.g.
haemorrhoids, ﬁssures, pruritis) are frequently seen in HIV/
AIDS patients and in the absence of routine screening may
be the primary reason for seeking medical help. (2) Diseases
associated with high-risk behaviours such as anoreceptive
intercourse. Included in this group are the STDs which cause
proctitis and anogenital ulcerations. (3) Those illnesses associ-
ated with HIV infection such as HIV anal ulceration, unusual
opportunistic infections, Kaposi’s sarcoma and lymphoma.
The distribution of the most common anorectal pathologies
reported in HIV patients include anal ulcer (29–32%), anal
condyloma (32–43%), anal ﬁssure (6–33%), anal ﬁstula (6–
33%), perirectal abscess (3–25%) and haemorrhoids (4–
14%).6 AIDS-associated ulcers are most commonly associated
with patients with clinical AIDS and lower CD4 counts and it
appears that since the introduction of HAART it is a less com-
mon clinical problem.27 However, one published series has re-
ported no change in the prevalence and distribution of anal
pathology (including AIDS ulcers) since the introduction of
HAART.6
Internal haemorrhoids most commonly presents with symp-
toms of bleeding or prolapse. HIV-positive patients are treated
along the same treatment schedule as HIV-negative patients.
Initial management is with increased dietary ﬁbre, bulking
agents and topical preparations. Those that remain symptom-
atic are treated with local measures such as rubber band liga-
tion, infrared coagulation or sclerotherapy.4 There were no
complications related to banding and 91% of patients had at
least some improvement of their presenting symptoms.12
Haemorrhoidectomy is indicated in patients who fail conserva-
tive treatments. The results of haemorrhoidectomy in HIV-po-
sitive patients have been conﬂicting, most likely because of
difference in the severity of AIDS. Hewitt et al.13 found no dif-
ference in wound healing times in HIV-negative vs. HIV
positive, HIV positive vs. HIV/AIDS, or CD4+ > 200 vs.
CD4+ < 200. However, Morandi et al.10 found 50% of pa-
tients with AIDS failed to heal in 32 weeks after haemorrhoi-
dectomy. The two factors most associated with poor wound
healing were AIDS and Karnofsky’s performance score. Tak-
ing these studies into account haemorrhoidectomy should be
offered to HIV-positive patients without AIDS based on stan-
dard indications just as for HIV-negative patients. AIDS pa-
tients with more advanced disease, low CD4+ counts (<100)
or poor performance status are at increased risk. The beneﬁts
of resolution of symptoms must be balanced against this risk.
Acute anorectal abscesses are treated by incision and drain-
age of the abscess and mushroom catheter (malecot) placed for
5–7 days. Broad spectrum antibiotics are prescribed especially
if there is any associated cellulitis.4 Fistula treatment in pa-
tients with AIDS and decreased CD4+ or leucocytes is similar
to those of Crohn’s patients with draining setons placed tocontrol sepsis. Fistulas in HIV/AIDS with normal counts are
treated with the same treatment algorithm as HIV-negative
patients.3,4,18
Idiopathic anal ﬁssures in HIV-positive patients must be dis-
tinguished from HIV-associated ulcers and STDs that cause
anogenital ulcers.14 Treatment is similar to that of the HIV-
negative population starting with conservative measures such
as warm soaks, stool softeners and topical ointments. Anore-
ceptive intercourse is discouraged. Two percent diltiazem oint-
ment applied two to three times daily to the anus or botulinum
toxin injected into the internal anal sphincter is alternative
treatments to surgery in patients who do not respond to initial
conservative measures. Lateral internal anal sphincterotomy is
appropriate for patients who fail conservative measures but do
not have chronic diarrhoea or pre-existing incontinence. Alter-
natively a cutaneous advancement ﬂap is preferred in those
with a contraindication to sphincterotomy.4
AIDS-associated anal ulcers are a distinct disease process
from typical anal ﬁssures. Clinically they both result in painwith
defaecation, but AIDS ulcers are more likely to result in dis-
abling pain unrelated to bowelmovements.15Diarrhoea encour-
ages anal ulceration and stool cultures for salmonella, shigella,
campylobacter and cryptosporidium with microscopy for giar-
dia, ova cysts and amoebae are mandatory.4 On examination
AIDS ulcers are differentiated by their location proximal to
the dentate line with a broad-based ulcer which may dissect be-
tween tissue planes. The presence of a cavity contributes to stool
and pus trapping whichmay explain the severity of pain. Biopsy
identiﬁes treatable aetiologies of these ulcers, including HSV,
CMV, Treponema pallidum. mycobacterium, cryptococcus,
Haemophilus ducreyi,Chlamydia trachomatis and cancer.4 Long
term cultures from an ulcer basemay reveal mycobacterium avi-
um intracellulare. Viral cultures can detect CMV or acyclovir-
resistant strains of HSV which can both cause extensive anal
ulceration. CMV can also be detected on rectal biopsy. Isolated
CMV proctitis is uncommon and presents with non-speciﬁc
symptoms like tenesmus, diarrhoea and haematochezia. Medi-
cal treatment of CMV requires either intravenous ganciclovir
or intravenous forscarnet, lasting 3–6 weeks depending on clin-
ical response.16 As ulcer healing is not common the goal of sur-
gical treatment is pain relief effected by debridement, unrooﬁng
cavities (to eliminate trapping) and repeat intralesional steroid
injection for recurrent pain.15
Anal warts Human Papilloma virus (HPV) is a DNA virus
that is the cause of viral warts on the skin and the genitalia.
HPV infection is spread by direct contact with infected skin
or ﬂuid and is frequently silent in 70% of sexually active peo-
ple. It becomes more clinically apparent as anal warts in the
immunosuppressed HIV/AIDS patient.17 Anal intercourse is
not required for anal infection to occur. Low-risk (non-
oncogenic) HPV serotypes such as HPV 6 and 11 account
for the majority of anogenital warts. Anal warts in AIDS pa-
tients tend to be aggressive, dysplastic and harder to eradicate.
As with other viral infections, it is impossible to eradicate the
causative human papilloma virus (HPV) infection by surgical
excision. For this reason the surgical excision of condylomas
is effectively performed more for relief of symptoms and cos-
mesis.18 Excision may have the beneﬁt of providing tissue for
histopathology in recurrent or atypical appearing lesions or
in HIV-positive patients. Electrocautery is satisfactory for iso-
lated warts but precise scissor excision on a bleb of raised skin
is preferable for extensive warts to preserve the intervening
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is the problem of aerosolised active viral particles in the laser
plume and cases of medical providers developing condylomata
in the respiratory tract have been reported. Transmission of
viral particles appears to be less of a problem with the lar-
ger-particle smoke from electrocautery.4 Topical podophyllin
or 5% 5-ﬂuorouracil cream applied through a proctoscope is
time consuming, tedious and often of little beneﬁt with high
recurrence rates.19 Excision has produced the best results for
anal condylomata but topical 5% imiquimod cream has shown
promise. By acting as a local immunomodulator that induces
a-interferon, tumour necrosis factor-a and other cytokines it
has the potential to eradicate HPV from the mucocutaneous
surfaces adjacent to gross lesions, which could decrease recur-
rences and treatment failures. Complete resolution of lesions
occurs in >50% of cases and additional patients experience
a substantial reduction of wart volume.20 Recurrences occur
in 10–20%. Imiquimod can be used as solitary therapy, ‘debul-
king’ large condylomata in order to minimise pain and ﬁbrosis
caused by fulgaration/excision, treating early recurrences after
surgical treatment or as ‘adjuvant’ treatment after surgical
treatment. Females should undergo regular cervical colposcop-
ic screening because of the associated risk of cervical cancer.21
There is good evidence that severe dysplasia may progress to
Ca-in situ and thence to squamous cell cancer. A quadrivalent
HPV vaccine against the high risk (oncogenic) serotypes HPV
6, 11, 16 and 18 is now available but its use is prophylactic.
Current recommendations are to vaccinate females before
exposure to HPV. No data are available on the efﬁcacy of this
vaccine for preventing anogenital HPV in males.22
Neoplasia Malignant neoplasia is remarkably of high inci-
dence for young people with HIV/AIDS.3,4,25 This includes
non-Hodgkin’s lymphoma in the perianal area.25 When this pre-
sents in the ischio-rectal fossa, it can look exactly like a tense
ischio-rectal abscess. It is tense, hot and tender, but solid. The
temptation in the middle of the night is for the junior doctor to
plunge a knife into and let all the pus out. The diagnosis can be
made by a needle biopsy via the perineum. A biopsy should
not be taken inside the anal canal as the patient will develop
a ﬁstula in the lymphomatous tissue.4 Kaposi’s sarcoma may
resemble an ulcerated haemorrhoid and is treated by radio-
therapy. Excision usually leaves a painful unhealed ulcer.26
HPV and anal cancer The anal canal and cervix are similar
in histology in that each case has a squamous-columnar tran-
sition zone and has led to the suggestion that anal HPV may
progress through grades of dysplasia to invasive cancer and
is the basis for screening and treatment strategies aimed at
identifying these premalignant changes.23,28 Anal Pap smears
are one screening test that has been suggested for homosexual
men, especially those that are HIV-positive.18 Squamous cell
carcinoma may be mistaken for a small benign ulcer and so
biopsy is mandatory.27 The annual incidence of anal cancer
in the USA is estimated at about 4000. The incidence in
HIV-negative homosexuals is roughly 35 times that rate and
further doubled in HIV-positive males.27 It appears that in
the HAART era this rate has not been decreased.24 Even so,
it is a rare condition perhaps because the rate of progression
is slower than the natural history of the HIV disease. The pre-
malignant anal carcinoma in situ lesion may be rapidly pro-
gressive in immunocompromised patients (transplant
recipients and HIV patients), but as the rate of progression
is slower than the natural history of HIV disease there is a needfor caution when considering treatment.4 Radiotherapy may
be helpful for symptomatic cases. A less aggressive approach
so as to prevent anal stenosis is to excise or biopsy/destroy
only gross lesions and submit the remainder to close observa-
tion. Chemo-irradiation is the treatment of choice for most
invasive anal cancers.28 Salvage abdominoperineal resection
(APR) can be useful if the CD4 count is >200, otherwise
the perineal wound will not heal.4,29,30
Traumatic anal ﬁssures may also result from changes in bo-
wel habit, colitis, proctitis or the trauma of ano-rectal inter-
course. Anal ulcers can be iatrogenic occurring in the region
of a previous lateral sphincterotomy initially performed for
an ulcer which was mistaken for a ﬁssure. Inappropriate anal
instrumentation or ‘ﬁsting’ injuries can result in the most hor-
rendous sphincter injuries which usually require permanent
faecal diversion. American proctologists see very massive and
erosive ulcers, which actually erode their way through the anal
canal. Setons are recommended for most ﬁstulae.4,5
5. Conclusions
Sexually transmitted diseases incuding HIV affecting the ano-
rectum are common and increasing in frequency. A high index
of suspicion and knowledge of the anorectal lesions is required
for diagnosis and treatment. An appropriate sexual history is
important in diagnosing these conditions. It appears that
HAART has not decreased the incidence of anorectal pathol-
ogy in HIV infected patients but may have decreased the
progression and complications pre-and postoperatively. Oper-
ations for anorectal pathology still represent one of the most
common indications for surgery in HIV-positive patients.
The best predictor of perioperative morbidity and mortality
is ASA/Korsakoff’s performance scores that measure general
health. Aggressive surgical intervention must be undertaken
with caution in patients with AIDS. Symptomatic improve-
ment of the underlying pathology may make delayed wound
healing an acceptable complication in many instances. Educa-
tion and sexual health promotion are necessary for the preven-
tion of HIV and its anorectal disorders.References
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